Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BBIO
BBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBIO News
Acoramidis Shows Kidney Protective Effects in ATTR-CM Patients
6d ago
Newsfilter
Alnylam Pharmaceuticals Shares Drop 24%, Yet Optimism Persists
6d ago
Fool
Alnylam Pharmaceuticals Reports Strong Q1 Performance
6d ago
NASDAQ.COM
BridgeBio Pharma Secures $1B Investment in Convertible Preferred Equity
Jul 01 2026
seekingalpha
BridgeBio Secures $1 Billion Preferred Equity Investment
Jul 01 2026
Newsfilter
KKR and Sixth Street Partners Invest $1B in BridgeBio Pharma
Jul 01 2026
seekingalpha
BridgeBio Releases PROPEL 3 Phase Data for Achondroplasia
Jun 28 2026
Newsfilter
BridgeBio Pharma Approves Employee Equity Grant Plan
Jun 23 2026
Newsfilter
NeOnc Secures Abu Dhabi IND Authorization for NEO212
Jun 22 2026
Newsfilter
BridgeBio Presents New Data at International Congress on Children's Bone Health
Jun 22 2026
Newsfilter
DKSH Partners with BridgeBio for ATTR-CM Treatment Access
Jun 11 2026
Yahoo Finance
Wall Street's Latest Ratings Overview
Jun 03 2026
CNBC
BridgeBio Pharma's BBP-418 Receives FDA Priority Review
May 27 2026
seekingalpha
BridgeBio's BBP-418 Receives FDA Priority Review for LGMD2I/R9
May 27 2026
Newsfilter
BridgeBio Pharma Shares Drop After Downgrade by Raymond James
May 26 2026
seekingalpha
Cardiovascular Disease Costs Set to Skyrocket, Urgent Need for AI Solutions
May 12 2026
PRnewswire
Show More News
